Deep-pocketed investors have adopted a bearish approach towards CVS Health CVS, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in CVS usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 11 extraordinary options activities for CVS Health. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 45% leaning bullish and 54% bearish. Among these notable options, 8 are puts, totaling $587,869, and 3 are calls, amounting to $211,402.
Expected Price Movements
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $40.0 and $55.0 for CVS Health, spanning the last three months.
Analyzing Volume & Open Interest
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for CVS Health's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across CVS Health's significant trades, within a strike price range of $40.0 to $55.0, over the past month.
CVS Health Option Volume And Open Interest Over Last 30 Days
Biggest Options Spotted:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CVS | PUT | SWEEP | BEARISH | 01/16/26 | $13.85 | $13.7 | $13.85 | $55.00 | $191.1K | 18.5K | 1.8K |
| CVS | PUT | TRADE | BEARISH | 01/16/26 | $14.75 | $13.85 | $14.42 | $55.00 | $181.6K | 18.5K | 0 |
| CVS | CALL | SWEEP | BEARISH | 02/21/25 | $5.85 | $5.75 | $5.75 | $40.00 | $108.6K | 261 | 302 |
| CVS | PUT | SWEEP | BULLISH | 05/16/25 | $6.6 | $6.5 | $6.5 | $47.50 | $69.5K | 812 | 94 |
| CVS | CALL | SWEEP | BEARISH | 02/21/25 | $5.85 | $5.75 | $5.75 | $40.00 | $63.8K | 261 | 2 |
About CVS Health
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the us. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It also operates a top-tier health insurer (acquired through Aetna) where it serves about 26 million medical members. The company's recent acquisition of Oak Street adds primary care services to the mix, which could have significant synergies with all its existing business lines.
After a thorough review of the options trading surrounding CVS Health, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
Current Position of CVS Health
- Trading volume stands at 2,561,563, with CVS's price up by 2.01%, positioned at $45.14.
- RSI indicators show the stock to be may be oversold.
- Earnings announcement expected in 41 days.
Professional Analyst Ratings for CVS Health
A total of 1 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $66.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. Click here for access. * In a positive move, an analyst from Deutsche Bank has upgraded their rating to Buy and adjusted the price target to $66.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for CVS Health, Benzinga Pro gives you real-time options trades alerts.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
